Summary
Cardinal Health Inc. (CAH) filed an 8-K on March 19, 2013, to disclose the impending termination of its pharmaceutical distribution agreement with Walgreen Co. This agreement is set to conclude in August 2013. This development is significant as it directly impacts a key customer relationship for Cardinal Health's pharmaceutical distribution segment. Investors should closely monitor the company's strategy and its efforts to mitigate the financial and operational impact of this contract's expiration.
Key Highlights
- 1Cardinal Health announced the termination of its pharmaceutical distribution agreement with Walgreen Co.
- 2The agreement is scheduled to end in August 2013.
- 3This disclosure was made via a press release included as an exhibit to the 8-K filing.
- 4The termination represents a material customer loss for Cardinal Health's distribution business.
- 5Investors will need to assess the impact on Cardinal Health's revenue and future growth prospects.
- 6The company will likely need to focus on retaining or acquiring new distribution partners to offset this loss.